About Us
Focus on the development of new antibody drugs for the treatment of tumors and autoimmune inflammatory diseases

About Us

/
Corporate Vision

Corporate Vision

  • Categories:关于我们
  • Time of issue:2020-06-18 00:00:00
  • Views:0
Description:
Description:
Coporate Vision
As a clinical stage biotech company based on innovative immunology research, we root in China with the global vision to develop safe and highly efficacious novel treatments for cancer and autoimmune diseases.
 
Core Positioning
Based on our proprietary antibody research and technology platforms, and guided by our core strength in IP development and innovation, we aim to lead the development of new treatments based on novel targets in mono or combination therapies.
 

Scan the QR code to read on your phone

这是描述信息

Add

Zhong Guancun Biopharmaceutical Park, NO.5 Kaituo Road,

Haidian District, Beijing City, China, 10084

A1 Northern Building, 218 Xinghu St. Suzhou Industrial Park, Jiangsu Province, China, 215123

COPYRIGHT @2020 Suzhou xinkanghe Biomedical Technology Co., Ltd   京ICP备12345678   Power by 300.cn Beijing

这是描述信息

Follow us